Business Context and Reporting Period
This Form 8-K Current Report was filed by Accuray Incorporated on October 11, 2012. The filing reports significant changes in executive leadership and board composition effective October 11 and October 12, 2012.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. The document focuses exclusively on executive compensation and employment terms.
- New CEO Base Salary: $625,000 annually.
- Target Performance Bonus: 120% of annual base salary.
- Stock Options: 200,000 shares at fair market value, vesting 25% on the first anniversary and monthly thereafter over four years.
- Restricted Stock Units (RSUs): 200,000 units vesting in four equal annual installments.
- Performance-Based Market Stock Units: 300,000 total units (100,000 granted November 2012; 200,000 granted February 2013).
- Outgoing CEO Consulting Fee: $20,500 per month (subject to agreement negotiation).
Material Changes
The primary material change is the departure of Dr. Euan S. Thomson, Ph.D., who resigned as President, Chief Executive Officer, and Board Director on October 11, 2012. Effective October 12, 2012, Joshua H. Levine was appointed President, Chief Executive Officer, and Board Director to fill the vacancy.
Guidance, Outlook, and Risks
The filing contains no financial guidance or outlook. Key contingencies and risks include:
- Severance Obligations: Mr. Levine is entitled to 12 months of base salary and a prorated bonus if terminated without cause. In a change of control where his position is not assumed, he is entitled to double severance, 200% of the target bonus, and acceleration of all unvested options.
- Outgoing CEO Negotiations: A General Release and Separation Agreement and a Consulting Services Agreement with Dr. Thomson are currently being negotiated.
- Leadership Transition: The company is undergoing a transition of top executive leadership.
Investor Verification Checklist
- Verify the final terms of the Separation Agreement and Consulting Services Agreement with Dr. Thomson.
- Confirm the grant date and fair market value used for Mr. Levine's stock options.
- Review the specific vesting conditions for the 300,000 performance-based market stock units.
- Monitor the integration of Mr. Levine's strategic vision and commercial leadership experience into the company's operations.